在肝细胞癌的发病,诊断和预后中miRNA的作用
Yi Lv1, Xiujuan Sun2
1Hepatobiliary and Pancreatic Surgery, Liuzhou People's Hospital, Liuzhou, Guangxi, China.
Chemical biology & drug design
|September 19, 2023
概括
微RNAs (miRNAs) 是肝细胞癌 (HCC) 的诊断和预后标志物,是癌症死亡的主要原因. 鉴定特定的miRNAs可能会导致更好的早期检测和针对性治疗HCC.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 肝细胞癌 (HCC) 是一种全球普遍存在的癌症,生存率低,需要改进诊断和预后工具.
- 目前对HCC的治疗有效性有限,这凸显了急需新型生物标志物的迫切需要,以便早期检测和有效管理.
- 微RNAs (miRNAs) 正在成为癌症发展和进展的关键调节者,包括HCC.
研究的目的:
- 审查了解miRNAs在肝细胞癌 (HCC) 中的作用的最新进展.
- 探索miRNAs作为HCC的诊断,预后和治疗标记物的潜力.
- 要总结改变miRNA表达如何影响HCC细胞行为,血管新生和耐药性.
主要方法:
- 对HCC中miRNAs最近研究的综合文献综述.
- 分析了详细介绍HCC组织中miRNA表达特征的研究.
- 检查特定miRNAs在HCC病变发生中的功能作用,包括迁移,入侵和血管生成.
主要成果:
- 特定miRNAs的改变表达显著影响HCC细胞迁移,入侵和血管生成.
- 外体miRNAs在促进HCC的血管生成,转移和化学抵抗方面发挥着至关重要的作用.
- 在HCC组织中miRNAs的差异表达为诊断和预后应用提供了潜力.
结论:
- 微RNAs (miRNAs) 在HCC发育和进展中起着关键作用,作为潜在的生物标志物.
- 针对miRNA表达的向调节可能为HCC提供新的治疗策略.
- 对新型miRNA及其差异表达的进一步研究对于改善HCC患者的治疗结果至关重要.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K


